PA
RETA

Perceptive Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Perceptive Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$68.3M Sell
2023
Q1 		$197M Buy
2022
Q4 		– Sell
2022
Q3 		$2.51M Buy
2022
Q2 		– Sell
2022
Q1 		$1.46M Buy
2018
Q4 		– Sell
2018
Q3 		$791K Buy